메뉴 건너뛰기




Volumn 10, Issue 4, 2009, Pages 165-168

Sepsis and multiple organ failure

Author keywords

critical care; infection; multiple organ failure; pathophysiology; sepsis; systemic inflammatory response syndrome

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; DOPAMINE; HYDROCORTISONE; NORADRENALIN; VASOPRESSIN;

EID: 63649149166     PISSN: 14720299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpaic.2009.01.008     Document Type: Review
Times cited : (15)

References (7)
  • 1
    • 0037396875 scopus 로고    scopus 로고
    • International Sepsis Definitions Conference 2001
    • Levy M.M., Fink M.P., Marshall J.C., et al. International Sepsis Definitions Conference 2001. Intensive Care Med 29 (2003) 530-538
    • (2003) Intensive Care Med , vol.29 , pp. 530-538
    • Levy, M.M.1    Fink, M.P.2    Marshall, J.C.3
  • 2
    • 37549020378 scopus 로고    scopus 로고
    • Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock 2008
    • Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock 2008. Crit Care Med 36 (2008) 296-327
    • (2008) Crit Care Med , vol.36 , pp. 296-327
    • Dellinger, R.P.1    Levy, M.M.2    Carlet, J.M.3
  • 3
    • 0035829842 scopus 로고    scopus 로고
    • Early goal-directed therapy in the treatment of severe sepsis and septic shock
    • Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
    • (2001) N Engl J Med , vol.345 , pp. 1368-1377
    • Rivers, E.1    Nguyen, B.2    Havstad, S.3
  • 4
    • 0035826096 scopus 로고    scopus 로고
    • Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: efficacy and safety of recombinant human activated protein C for severe sepsis
    • Bernard G.R., Vincent J.L., Laterre P.F., et al. Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
    • (2001) N Engl J Med , vol.344 , pp. 699-709
    • Bernard, G.R.1    Vincent, J.L.2    Laterre, P.F.3
  • 5
    • 0037151571 scopus 로고    scopus 로고
    • Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    • Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
    • (2002) JAMA , vol.288 , pp. 862-871
    • Annane, D.1    Sebille, V.2    Charpentier, C.3
  • 6
    • 38049110809 scopus 로고    scopus 로고
    • Hydrocortisone therapy for patients with septic shock
    • Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 (2008) 111-124
    • (2008) N Engl J Med , vol.358 , pp. 111-124
    • Sprung, C.L.1    Annane, D.2    Keh, D.3
  • 7
    • 40049109098 scopus 로고    scopus 로고
    • Vasopressin versus norepinephrine infusion in patients with septic shock
    • Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358 (2008) 877-887
    • (2008) N Engl J Med , vol.358 , pp. 877-887
    • Russell, J.A.1    Walley, K.R.2    Singer, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.